Advertisement

Topics

BRIEF-Richter signs deal with DM Bio for biosimilar cancer medicine

22:15 EDT 18 Oct 2016 | Reuters

* Has signed an agreement with DM Bio for development and sale of biosimilar medicine trastuzumab.

Original Article: BRIEF-Richter signs deal with DM Bio for biosimilar cancer medicine

NEXT ARTICLE

More From BioPortfolio on "BRIEF-Richter signs deal with DM Bio for biosimilar cancer medicine"

Quick Search
Advertisement
 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...